Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduction of Anticholinergic Medications Project (RAMP) Among Persons With Schizophrenia or Other Psychiatric Disorders Across UPMC Behavioral Healthcare Partner Organizations Using a Stepped-wedge, Randomized Trial Study Design.

NCT07043803 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT07043803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07043803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduction of Anticholinergic Medications Project (RAMP) Among Persons With Schizophrenia or Other Psychiatric Disorders Across UPMC Behavioral Healthcare Partner Organizations Using a Stepped-wedge, Randomized Trial Study Design.
Lead sponsor
University of Pittsburgh
Phase
Not applicable
Overall status
Completed
Start date
July 16, 2025
Completion date
May 31, 2026
Enrollment
53 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, psychiatric disorders, schizoaffective disorder, schizophenia disorder